-
News | 2023.07.24
Framework Agreement between the Institut Pasteur and Fiocruz for the Development of Innovation and Technology Transfer
The Institut Pasteur and the Oswaldo Cruz Foundation (Fiocruz) have a long-standing partnership, mirroring the strong ties between France and Brazil, which have maintained a privileged relationship in the fields of public health and biomedical research for over a century. With this framework agreement, the two institutions reinforce their bilateral relations while leveraging the complementarity...
-
Document de presse | 2023.07.27
Remission from HIV-1 infection: discovery of broadly neutralizing antibodies that contribute to virus control
Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms enabling this post-treatment control have not been fully elucidated. For the first time, teams of scientists from the Institut Pasteur, Inserm and the Paris Public Hospital Network (AP-HP), supported by...
-
News | 2023.08.17
ECOMORE 2: understanding environmental impact on the emergence of infectious diseases in Southeast Asia.
Due to population growth and economic development, our planet is experiencing significant changes in natural ecosystems that may lead to the re-emergence of infectious diseases. For 5 years, ECOMORE 2 project, coordinated by Institut Pasteur in partnership with the Institut Pasteur du Cambodge, the Institut Pasteur du Laos, the National Health Laboratory (NHL) of Myanmar, the Research Institute...
-
Document de presse | 2023.08.09
SARS-CoV-2: how the history of human populations influences their immune response
During the COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS and the Collège de France, in collaboration with researchers around the world1 , have investigated the extent and drivers of differences in immune responses to SARS-CoV-2 across populations from Central Africa...
-
News | 2023.08.23
Distinct immune responses reveal two major types of long COVID
Although the biological mechanisms behind the short-term effects of COVID-19 are now known, the same is not true for long COVID. Scientists have recently demonstrated that individuals with this syndrome can present different immune responses, either weak or strong. This is a first step in improving treatment for patients with no apparent immunological traces of SARS-CoV-2 infection.
-
Document de presse | 2023.09.08
How the respiratory tract microbiome influences the severity of bacterial pneumonia
Pneumonia is an infection of the lung alveoli caused by bacteria, viruses or fungi. It is one of the leading causes of morbidity and mortality worldwide, representing a clinical and economic burden and a global public health problem. The microbial ecosystem (or microbiome) of the human respiratory tract colonizes different niches. The respiratory tract microbiome is of interest to scientists as...
-
Article | 2023.09.18
Laveran Class (2023-2026)
Promotion PPU 2023-2026PhD studentMaster degree studiesLaboratoryPhD DirectorLab HeadPhD ProjectDoctoral schoolPPU studentsBARONE KristaNew York University, New York, United StatesMacrophages and Endothelial CellsOBINO DorianGOMEZ-PEDIGUERO ElisaRole of perivascular macrophages in physiology and pathologyBioSPC - ED 562ESCOBAR RODRIGUEZ MarianaUniversity of Groningen, the Netherlands and...
-
Document de presse | 2023.09.19
Development of an onco-therapeutic vaccine candidate against human papillomavirus (HPV)-induced cancers, based on preclinical results showing 100% efficacy
The Biotech TheraVectys, in collaboration with Institut Pasteur-TheraVectys Joint Laboratory, has just demonstrated the preclinical efficacy of its "Lenti-HPV-07" lentiviral vector-based vaccine candidate, administered intramuscularly, against cervical and oropharyngeal cancers induced by human papillomavirus (HPV). These results were published in EMBO Molecular Medicine journal on September 7,...
-
News | 2023.09.11
Food safety and antibiotic resistance: the fight against Listeria and Salmonella
The Fondation Le Roch-Les Mousquetaires is supporting two research projects at the Institut Pasteur on food safety and combating antibiotic resistance.
-
Document de presse | 2023.09.28
Malaria: treatment of Plasmodium falciparum malaria patients under threat in the Horn of Africa
Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa. Scientists from the Laboratory of Parasitology and Medical Mycology at the University of Strasbourg and Strasbourg University Hospital, in...
